FDA
-
-
-
-
-
-
-
MIMEDX secures exclusive US distribution rights for wound gel product
-
-
-
-
-
-
-
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results
-
-
-
-
-
-
-
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
-
-
-
-
-
-
-
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook
-
-
-
-
-
-
-
MIMEDX Announces Third Quarter 2022 Operating and Financial Results
-
-
-
-
-
-
-
MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results
-
-
-
-
-
-
-
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
-
322,198 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

